Available Volunteer Opportunities Chair and Vice-Chair for Youth Advisory Council – Virtual Chair and Vice-Chair for Youth Advisory Council  To integrate the youth perspective in developing youth and young adult […]

Bone Health & Osteoporosis Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which can lead to increased risk of fracture. Nutrition and exercise can […]

November is Osteoporosis Month BREAK MYTHS. NOT BONES Osteoporosis Canada has launched a new awareness campaign this November for Osteoporosis Month – Break Myths. Not Bones. We want to break […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

  Our Financials YEAR ENDED MARCH 31, 2022 Osteoporosis Canada’s Program Fund, which accounts for revenue and expenses related to education, advocacy and awareness, administration, and fundraising, had a year-end […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]